GENE

Genetic Technologies Share Price

3.96
0.13 (3.39%)
Upgrade to Real-Time
Afterhours (Closed)
3.96
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.13 3.39% 3.96 19:40:09
Open Price Low Price High Price Close Price Prev Close
3.83 3.80 4.08 3.98 3.83
Bid Price Ask Price Spread News
3.96 4.05 0.09 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
966 180,418  3.98  718,790 3,759,928 1.41 - 10.30
Last Trade Time Type Quantity Stock Price Currency
19:40:09 formt 130  3.96 USD

Genetic Technologies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 54.53M 13.77M 13.77M  7.61k  - -0.62 -8.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News Genetic Technologies

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

GENE Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.


Your Recent History
NASDAQ
GENE
Genetic Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.